Annual Shareholder Meeting Presentation
Annual_Meeting_2010.pdf (The presentation has a size of 1.2 MB)

Webcast: PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056
webcast_60056_LMWH_6-9-10.pdf (The presentation has a size of 1.2 MB)

32^nd Annual Meeting of the Society of Cardiovascular Anesthesiologist
April 26 – 28, 2010 New Orleans, LA
polymedixSCAPoster.pdf (The presentation has a size of 0.08 MB)

Replay of April 7, 2010 PMX-30063 Phase 1B Results Webcast
http://investor.shareholder.com/media/eventdetail.cfm?eventid=79828

8^th World Congress on Trauma, Shock, Inflammation and Sepsis – TSIS 2010 (Munich, Germany, March 11, 2010)

TSIS2010_Munich_11March.pdf  (The presentation has a size of 0.6 MB)
An Approach to New Antibiotics for Avoiding Resistance: PMX-30063

Replay of December 15,2009 Heptagonist WebCast

http://events.vcall.com/VCall/ReplayLogin.aspx?room=2146004559

American Society of Hematology, 51st Annual Meeting and Exposition
(New Orleans, Louisiana, December 5-9, 2009)

ASHDec0917898.pdf  (The presentation has a size of 0.09 MB)
Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs

49th ICAAC - Interscience Conference on Antimicrobial Agents and Chemotherapy (Sep. 2009, San Francisco, Ca.)

ICAAC2009PKPD.pdf  (The presentation has a size of 1.1 MB)
Pharmacokinetic-Pharmacodynamic Relationship for PMX30063 in the nmouse thigh burden model

ICAAC2009Clinical.pdf  (The presentation has a size of 1.1 MB)
Human safety and Pharmacokinetic of PMX-30063, a small nonpeptidic mimic of the host defense proteins

ICAAC2009Weiss.pdf  (The presentation has a size of 0.2 MB)
Efficacy of PMX30063 in Experimental Staphylococcal Skin and Skin Structure Infection Models
 

ISTH – 1089
In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative
ISTH-7-16-09_1089.pdf  (The presentation has a size of 0.15 MB)

ISTH -- 1104
Ex Vivo Neutralization ofEnoxaparin in Primates by a Novel Heparin Antagonist
ISTH-7-16-09_1104.pdf  (The presentation has a size of 0.10 MB)

ISTH – 2514
In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative
ISTH-7-16-09_2514.pdf  (The presentation has a size of 0.10 MB)

American Society of Microbiology 109th General Meeting

Titled "Antimicrobial Systemic Antibiotics: Small Molecule Mimics of Host Defense Proteins," the poster describes the series of arylamide foldamers that are designed to mimic the activities of naturally occurring antimicrobial peptides (synthetic small molecule defensin mimetics). These molecules showed high levels of activity against both Gram-positive and Gram-negative bacteria with minimal toxicity mammalian cells. The goal of this study was to understand their mechanism of action and lack of toxicity.

ASMGeneral2009.pdf
(The presentation has a size of 1.1 MB)

5th European Conference on Clinical and Social Research on AIDS and Drugs

Beyond INH: New classes of drug development for the treatment of multi-drug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) infections and global vulnerabilities of HIV+ drug users is a determining consideration for the development of defensin mimetics

AIDS_Vilnius2009_Website.pdf
(The presentation has a size of 3.1 MB)

Healthtech Conference – The Challenge of Antibacterial Drug Development – A New Antibacterial Class

HealthtechConfSanDiegoMar2009_30063.pdf
(The presentation has a size of 1.1 MB)

Small Molecule Mimics of Antimicrobial Peptides as Antimalarials by Dr. Doran Greenbaum, March 23, 2009

Keystone Malaria Greenbaum 3-23-09
(The presentation has a size of 1.1 MB)

Superbugs & Superdrugs - A Focus on Antibacterials
18th to 19th March 2009

Superbugs18-19March09.pdf
(The presentation has a size of 0.9 MB)

Keystone Symposia Presentation, 2009
Antimicrobial Molecules for Treatment of TB

Keystone Symposia Presentation 2009
(The presentation has a size of 0.4 MB)

HIV DART Conference Decmber 10, 2008 San Juan, Puerto Rico8

HIV-DART 2008 TB Presentation
(The presentation has a size of 0.4 MB)

48th Annual ICAAC/IDSA 46th Annual Meeting in Washington, DC, Oct. 25-28, 2008

ICAAC 2008 PMX-30063 in vitro poster
(The presentation has a size of 1.3 MB)

ICAAC 2008 PMX-30063 in vivo poster
(The presentation has a size of 1.3 MB)

ICAAC 2008 Diamond Candida Albicans poster
(The presentation has a size of 0,05 MB)

Greenbaum Malaria presentation- ICAAC October 27 2008
(The presentation has a size of 1.6 MB)

PolyMedix AIDS Symposium TB presentation 9/26/08
(The presentation has a size of 0.2 MB)

Experimental Biology Meeting April 2008 – Unfractionated Heparin poster
(The presentation has a size of 0.1 MB)

Experimental Biology Meeting April 2008 – Low Molecular Weight Heparin poster
(The presentation has a size of 0.1 MB)

Thrombosis and Hemostasis Research Congress Heptagonist abstract 2-21-08
(The presentation has a size of 0.014 MB)

American Society of Microbiology poster February 2008
(The presentation has a size of 0.001 MB)

American Society of Hematology (ASH) Poster, December 2007s 

view as pdf

view as poster in browser window

There are currently 2 webcatsts available on healthradio.net

Potential Solutions to Resistant Infections, Including MRSA
Melanie Cole M.S. featuring Nicholas Landekic (CEO Polymedix)
Show Date2009-09-30

[ Listen to the complete webcast ]

Antibiotic Resistance: How “Mimicking” Nature may be The Key ...
Melanie Cole M.S. featuring Nicholas Landekic (CEO Polymedix)
Show Date2007-08-13

[ Listen to the complete webcast ]

Ocular Microbiology and Immunology Group Meeting, Campbell Lab presentation November 2
(The presentation has a size of 0.6 MB)

ICAAC poster September 2006
(8 MB ... high bandwidth version)

ICAAC poster September 2006
(0.2 MB ... easy download version)

You need the Adobe Acrobat Reader to view the presentations.
If you do not have the Acrobat Reader installed on your system you may optain a free copy of the software via this link: [ Adobe Acrobat Reader ]

return to top ^